Tonix Pharmaceuticals has reported positive topline outcomes from its Phase I single ascending dose study of its ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first ...

Tonix Pharmaceuticals (TNXP) stock jumped 11% Friday after the company issued a business update along with a preliminary 2024 ...

Tonix shares are moving higher on Friday after the company provided preliminary 2024 fiscal-year financial results.

Tonix Pharmaceuticals saw its shares swing wildly between gains and losses on Wednesday morning as they started to trade ...

Clinical-stage biopharmaceutical company Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining significant attention from investors ...

EST Tonix Pharmaceuticals (TNXP) trading halted, news pendingMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Tonix ...

Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities ...